CD8A and prostate neoplasm: Taken together, we demonstrated that the adoptive transfer of BMDMs activated ex vivo with VSSP as an M1-polarizing agent, induced prostate tumor inhibition by increasing the functionality of tumor-infiltrating CD8+ T cells, reducing the density and the dimensions of the tumor-associated blood vessels and inducing tumor cell senescence.